Recurrent Salmonellosis in a Child with Complete IL-12Rβ1 Deficiency

Mohammad Faizan Zahid1, Syed Asad Ali2, Fyezah Jehan3

  • 1Medical College, Aga Khan University, Karachi 74800, Pakistan.

Journal of Immunodeficiency & Disorders
|December 30, 2014
PubMed

Insights

Recurrent Salmonella typhi infections in a child led to the diagnosis of Interleukin-12 Receptor Beta 1 (IL-12Rβ1) deficiency. This rare immunodeficiency highlights the need for early diagnosis in persistent salmonellosis cases.

Area of Science:

  • Immunology
  • Pediatrics
  • Infectious Diseases

Background:

  • Recurrent Salmonella typhi bacteremia can indicate underlying immunodeficiency.
  • Previous empirical anti-tuberculous therapy and negative lymphoma workup complicated the initial diagnosis.
  • A family history of suspected tuberculous meningitis and recurrent infections in the patient suggested a genetic predisposition.

Purpose of the Study:

  • To investigate the cause of recurrent Salmonella typhi bacteremia in a pediatric patient.
  • To identify potential immunodeficiencies contributing to persistent invasive salmonellosis.
  • To underscore the diagnostic significance of IL-12Rβ1 deficiency in recurrent salmonellosis.

Main Methods:

  • Clinical presentation analysis including fever, abdominal pain, and lymphadenopathy.
  • Microbiological investigations: blood and lymph node cultures for Salmonella typhi.
  • Immunological workup: HIV testing and genetic analysis for IL-12Rβ1 deficiency.

Main Results:

  • Blood and lymph node cultures confirmed Salmonella typhi infection.
  • Patient experienced recurrent episodes of Salmonella typhi bacteremia despite empirical treatments.
  • Genetic analysis revealed Interleukin-12 Receptor Beta 1 (IL-12Rβ1) deficiency.
  • The patient ultimately succumbed to complications including small bowel obstruction and endotoxic shock.

Conclusions:

  • IL-12Rβ1 deficiency is a critical consideration in children presenting with recurrent invasive salmonellosis.
  • Early diagnosis of IL-12Rβ1 deficiency is crucial for appropriate patient management and monitoring.
  • Management challenges, including financial constraints and treatment feasibility, impact outcomes in rare immunodeficiencies.